Pseudomonas aeruginosa

From Aaushi
Jump to navigation Jump to search

Etiology

risk factors

Epidemiology

Pathology

Clinical manifestations

Laboratory

Radiology

Complications

Management

More general terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th edition, Ewald & McKenzie (eds) Little, Brown & Co, 1995, pg 301
  2. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 227-228
  3. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 797
  4. 4.0 4.1 4.2 Journal Watch 21(17):140, 2001 Fiorillo L et al The pseudomonas hot-foot syndrome. N Engl J Med 345:335, 2001 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11484690
  5. 5.0 5.1 5.2 5.3 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17, 18. American College of Physicians, Philadelphia 2009, 2012, 2015, 2018
  6. 6.0 6.1 6.2 Pogue JM, Marchaim D, Kaye D, Kaye KS. Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy. 2011 Sep;31(9):912-21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21923592
  7. Cilloniz C, Gabarrus A, Ferrer M et al Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug- Resistant Pseudomonas aeruginosa. Chest. 2016 Aug;150(2):415-25. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27060725
  8. 8.0 8.1 8.2 8.3 Elkston CA, Elkston DM Bacterial Skin Infections: More Than Skin Deep. Medscape. July 19, 2021 https://reference.medscape.com/slideshow/infect-skin-6003449
  9. 9.0 9.1 NEJM Knowledge+